US-based healthcare data company Kyruus has raised $5.5m in its series A round from a consortium including US-based consultancy company the Gerson Lehrman Group (GLG).
The round was co-led by venture capital firms Highland Capital Partners and Venrock and included a number of angel investors with links to the health industry, including John Goldsmith, chairman of research and advisory firm Lux Research who also sits on the board at GLG, which in turn is backed by Silver Lake Partners and Bessemer Venture Partners.
Founded last year, Kyruus plans to use its p3 platform to use predictive analysis to improve the way in which physicians and patients are matched with each other.
Graham Gardner, chief executive of Kyruus, said: "Physicians are central agents of progress and innovation across our healthcare system. We are going after an incredible opportunity to assemble and leverage the many disparate silos of data that characterize those physicians and ensure that they are matched to the most valuable opportunities for collaboration in an effort improve patient care."
Two of Kyruus’ co-founders, Gardner and chief pharmaceutical officer Julie Yoo, were also involved in the Generation Health, a company for genetics testing benefits management, which was launched in November 2008 and similarly backed by Highland. A majority stake in the company was bought by US-based pharmaceutical services conglomerate CVS Caremark in December 2009.